157 related articles for article (PubMed ID: 6183554)
1. Tolerance develops to the haloperidol-induced increase in the efflux of dopamine metabolites from the brains of unanesthetized, freely-moving rats.
Nielsen JA; Duda NJ; Moore KE
Life Sci; 1982 Oct; 31(14):1495-1500. PubMed ID: 6183554
[TBL] [Abstract][Full Text] [Related]
2. Measurement of metabolites of dopamine and 5-hydroxytryptamine in cerebroventricular perfusates of unanesthetized, freely-moving rats: selective effects of drugs.
Nielsen JA; Moore KE
Pharmacol Biochem Behav; 1982 Jan; 16(1):131-7. PubMed ID: 6173884
[TBL] [Abstract][Full Text] [Related]
3. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
Nielsen JA; Moore KE
Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
[TBL] [Abstract][Full Text] [Related]
4. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
Zetterström T; Sharp T; Ungerstedt U
Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
[TBL] [Abstract][Full Text] [Related]
5. Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis.
Zetterström T; Ungerstedt U
Eur J Pharmacol; 1984 Jan; 97(1-2):29-36. PubMed ID: 6199219
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced changes in the efflux of dopamine and serotonin metabolites from the brains of freely moving rats.
Moore KE
Ann N Y Acad Sci; 1986; 473():303-20. PubMed ID: 2432822
[No Abstract] [Full Text] [Related]
7. Brain microdialysis study of the effects of hazardous chemicals on the central nervous system. 1. Changes in monoamine metabolites induced by cerebral methyl bromide administration measured by two-probe microdialysis (TPMD) method.
Honma T
Ind Health; 1992; 30(1):47-60. PubMed ID: 1377665
[TBL] [Abstract][Full Text] [Related]
8. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs.
Radhakishun FS; Korf J; Venema K; Westerink BH
Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209
[TBL] [Abstract][Full Text] [Related]
9. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
See RE
Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
[TBL] [Abstract][Full Text] [Related]
10. Dopamine metabolites and catalepsy after lithium and haloperidol.
Bowers MB; Rozitis A
Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptics increase striatal catecholamine metabolites but not ascorbic acid in dialyzed perfusate.
Blakely RD; Wages SA; Justice JB; Herndon JG; Neill DB
Brain Res; 1984 Aug; 308(1):1-8. PubMed ID: 6206916
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine loading increases dopamine metabolite concentrations in the brain.
Chance WT; Foley-Nelson T; Nelson JL; Fischer JE
Pharmacol Biochem Behav; 1990 Jan; 35(1):195-9. PubMed ID: 2315359
[TBL] [Abstract][Full Text] [Related]
13. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
Salamone JD; Keller RW; Zigmond MJ; Stricker EM
Brain Res; 1989 May; 487(2):215-24. PubMed ID: 2786443
[TBL] [Abstract][Full Text] [Related]
14. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
Pifl C; Pichler L; Kobinger W; Hornykiewicz O
Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928
[TBL] [Abstract][Full Text] [Related]
15. Chronic verapamil modifies striatal and frontal cortex dopamine levels.
Sitges M; Guarneros A
Eur Neuropsychopharmacol; 1998 May; 8(2):105-11. PubMed ID: 9619688
[TBL] [Abstract][Full Text] [Related]
16. Bilateral neurochemical changes induced by unilateral cerebral haloperidol administration: evidence for cerebral asymmetry in the rat.
Hyde JF; Jerussi TP
Pharmacol Biochem Behav; 1992 Jul; 42(3):457-64. PubMed ID: 1409779
[TBL] [Abstract][Full Text] [Related]
17. Analysis of extracellular DOPAC, HVA and 5-HIAA in rat striatum in vivo by differential pulse voltammetry: effect of phencyclidine, haloperidol and their coadministration.
Crespi F; Keane PE
Pharmacol Res Commun; 1987 Sep; 19(9):639-49. PubMed ID: 2448834
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
Toru M; Mataga N; Takashima M; Nishikawa T
Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
[TBL] [Abstract][Full Text] [Related]
19. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
Kito S; Shimoyama M; Arakawa R
Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
[TBL] [Abstract][Full Text] [Related]
20. Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats.
Becker JB; Adams F; Robinson TE
J Neurosci Methods; 1988 Jul; 24(3):259-69. PubMed ID: 2458511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
